Aventyn Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions

CARLSBAD, Calif.--()--Aventyn, an intelligent digital therapeutics company, has joined the American Heart Association® Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators’ Network is a consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” said Eric Peterson, M.D., M.P.H., vice provost and senior associate dean for clinical research at University of Texas Southwestern and volunteer chair of the Health Tech Advisory Group for the Center. “It’s incredibly encouraging to see Aventyn leveraging this consortium to broaden and deepen their engagement in this arena.”

“We are excited to join the Innovators’ Network, as it will provide opportunities to connect with others innovating in the health tech space as we pursue our goal of using health education, digital therapeutics, and risk assessments to improve outcomes,” said Navin Govind, founder and CEO of Aventyn, Inc.

About Aventyn

Aventyn joins the Innovators’ Network with an aim of using a data science based, health education approach to prevent hospitalizations and provide early treatment options. Solutions are focused on cohort risk screening and diagnosis, and include intelligent digital therapeutics including Vitalbeat®, a suite of solutions that offer health risk assessments and virtual care solutions.

Aventyn is a digital therapeutics company focused on connecting patients with clinicians via seamless sharing of interoperable clinical information, with a goal of precision chronic disease management, improved patient outcomes, and reduced hospital costs.


Puja Chandler, vitalbeat@aventyn.com